B&G FOODS INC (BGS) Fundamental Analysis & Valuation

NYSE:BGS • US05508R1068

Current stock price

4.87 USD
-0.18 (-3.56%)
At close:
4.9 USD
+0.03 (+0.62%)
After Hours:

This BGS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BGS Profitability Analysis

1.1 Basic Checks

  • BGS had positive earnings in the past year.
  • In the past year BGS had a positive cash flow from operations.
  • In the past 5 years BGS reported 4 times negative net income.
  • Each year in the past 5 years BGS had a positive operating cash flow.
BGS Yearly Net Income VS EBIT VS OCF VS FCFBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • BGS has a Return On Assets of -1.53%. This is in the lower half of the industry: BGS underperforms 60.92% of its industry peers.
  • BGS has a Return On Equity of -9.55%. This is in the lower half of the industry: BGS underperforms 63.22% of its industry peers.
  • BGS has a better Return On Invested Capital (5.55%) than 64.37% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BGS is in line with the industry average of 7.17%.
Industry RankSector Rank
ROA -1.53%
ROE -9.55%
ROIC 5.55%
ROA(3y)-3.94%
ROA(5y)-2.07%
ROE(3y)-21.78%
ROE(5y)-11.87%
ROIC(3y)5.85%
ROIC(5y)5.35%
BGS Yearly ROA, ROE, ROICBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With a decent Operating Margin value of 10.04%, BGS is doing good in the industry, outperforming 77.01% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BGS has declined.
  • BGS's Gross Margin of 21.81% is in line compared to the rest of the industry. BGS outperforms 55.17% of its industry peers.
  • In the last couple of years the Gross Margin of BGS has declined.
Industry RankSector Rank
OM 10.04%
PM (TTM) N/A
GM 21.81%
OM growth 3Y3.14%
OM growth 5Y-6.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.82%
GM growth 5Y-2.28%
BGS Yearly Profit, Operating, Gross MarginsBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

3

2. BGS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BGS is destroying value.
  • Compared to 1 year ago, BGS has more shares outstanding
  • The number of shares outstanding for BGS has been increased compared to 5 years ago.
  • BGS has a worse debt/assets ratio than last year.
BGS Yearly Shares OutstandingBGS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
BGS Yearly Total Debt VS Total AssetsBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • BGS has an Altman-Z score of 1.40. This is a bad value and indicates that BGS is not financially healthy and even has some risk of bankruptcy.
  • BGS has a worse Altman-Z score (1.40) than 63.22% of its industry peers.
  • BGS has a debt to FCF ratio of 27.56. This is a negative value and a sign of low solvency as BGS would need 27.56 years to pay back of all of its debts.
  • BGS has a Debt to FCF ratio (27.56) which is comparable to the rest of the industry.
  • BGS has a Debt/Equity ratio of 4.30. This is a high value indicating a heavy dependency on external financing.
  • BGS has a worse Debt to Equity ratio (4.30) than 85.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF 27.56
Altman-Z 1.4
ROIC/WACC0.74
WACC7.55%
BGS Yearly LT Debt VS Equity VS FCFBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 3.32 indicates that BGS has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.32, BGS belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
  • BGS has a Quick Ratio of 1.43. This is a normal value and indicates that BGS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BGS (1.43) is better than 75.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 1.43
BGS Yearly Current Assets VS Current LiabilitesBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2

3. BGS Growth Analysis

3.1 Past

  • The earnings per share for BGS have decreased strongly by -27.14% in the last year.
  • The earnings per share for BGS have been decreasing by -25.75% on average. This is quite bad
  • BGS shows a decrease in Revenue. In the last year, the revenue decreased by -5.37%.
  • BGS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.46% yearly.
EPS 1Y (TTM)-27.14%
EPS 3Y-23.07%
EPS 5Y-25.75%
EPS Q2Q%-9.68%
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-5.44%
Revenue growth 5Y-1.46%
Sales Q2Q%-2.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.19% on average over the next years. This is quite good.
  • The Revenue is expected to decrease by -0.65% on average over the next years.
EPS Next Y-0.7%
EPS Next 2Y15.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.68%
Revenue Next 2Y-0.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BGS Yearly Revenue VS EstimatesBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
BGS Yearly EPS VS EstimatesBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

7

4. BGS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.55, the valuation of BGS can be described as very reasonable.
  • Based on the Price/Earnings ratio, BGS is valued cheaper than 83.91% of the companies in the same industry.
  • BGS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.79.
  • BGS is valuated reasonably with a Price/Forward Earnings ratio of 9.62.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BGS indicates a rather cheap valuation: BGS is cheaper than 87.36% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of BGS to the average of the S&P500 Index (23.80), we can say BGS is valued rather cheaply.
Industry RankSector Rank
PE 9.55
Fwd PE 9.62
BGS Price Earnings VS Forward Price EarningsBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BGS is valued a bit cheaper than the industry average as 62.07% of the companies are valued more expensively.
  • 94.25% of the companies in the same industry are more expensive than BGS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.51
EV/EBITDA 9.2
BGS Per share dataBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BGS's earnings are expected to grow with 15.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.19%
EPS Next 3YN/A

5

5. BGS Dividend Analysis

5.1 Amount

  • BGS has a Yearly Dividend Yield of 14.45%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.46, BGS pays a better dividend. On top of this BGS pays more dividend than 98.85% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, BGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.45%

5.2 History

  • The dividend of BGS decreases each year by -16.37%.
  • BGS has paid a dividend for at least 10 years, which is a reliable track record.
  • BGS has decreased its dividend recently.
Dividend Growth(5Y)-16.37%
Div Incr Years0
Div Non Decr Years1
BGS Yearly Dividends per shareBGS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • BGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-140.09%
EPS Next 2Y15.19%
EPS Next 3YN/A
BGS Yearly Income VS Free CF VS DividendBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

BGS Fundamentals: All Metrics, Ratios and Statistics

B&G FOODS INC

NYSE:BGS (3/18/2026, 8:04:00 PM)

After market: 4.9 +0.03 (+0.62%)

4.87

-0.18 (-3.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-03
Earnings (Next)05-04
Inst Owners64.29%
Inst Owner Change-5.33%
Ins Owners3.72%
Ins Owner Change6.16%
Market Cap389.50M
Revenue(TTM)1.83B
Net Income(TTM)-43.26M
Analysts48.33
Price Target4.67 (-4.11%)
Short Float %13.86%
Short Ratio4.74
Dividend
Industry RankSector Rank
Dividend Yield 14.45%
Yearly Dividend0.76
Dividend Growth(5Y)-16.37%
DP-140.09%
Div Incr Years0
Div Non Decr Years1
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.98%
Min EPS beat(2)-7.59%
Max EPS beat(2)33.56%
EPS beat(4)1
Avg EPS beat(4)-20.26%
Min EPS beat(4)-74.14%
Max EPS beat(4)33.56%
EPS beat(8)2
Avg EPS beat(8)-18.59%
EPS beat(12)6
Avg EPS beat(12)-5.61%
EPS beat(16)7
Avg EPS beat(16)-4.6%
Revenue beat(2)0
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-0.45%
Max Revenue beat(2)-0.25%
Revenue beat(4)0
Avg Revenue beat(4)-2.73%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)-0.25%
Revenue beat(8)1
Avg Revenue beat(8)-1.99%
Revenue beat(12)2
Avg Revenue beat(12)-1.78%
Revenue beat(16)4
Avg Revenue beat(16)-1.02%
PT rev (1m)0%
PT rev (3m)1.85%
EPS NQ rev (1m)13.29%
EPS NQ rev (3m)13.29%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.85%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.55
Fwd PE 9.62
P/S 0.21
P/FCF 5.51
P/OCF 3.84
P/B 0.86
P/tB N/A
EV/EBITDA 9.2
EPS(TTM)0.51
EY10.47%
EPS(NY)0.51
Fwd EY10.4%
FCF(TTM)0.88
FCFY18.16%
OCF(TTM)1.27
OCFY26.03%
SpS22.86
BVpS5.66
TBVpS-16.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.06
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -9.55%
ROCE 7.03%
ROIC 5.55%
ROICexc 5.67%
ROICexgc 17.67%
OM 10.04%
PM (TTM) N/A
GM 21.81%
FCFM 3.87%
ROA(3y)-3.94%
ROA(5y)-2.07%
ROE(3y)-21.78%
ROE(5y)-11.87%
ROIC(3y)5.85%
ROIC(5y)5.35%
ROICexc(3y)5.96%
ROICexc(5y)5.44%
ROICexgc(3y)19.22%
ROICexgc(5y)17.87%
ROCE(3y)7.41%
ROCE(5y)6.78%
ROICexgc growth 3Y8.08%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y8.56%
ROICexc growth 5Y-2.05%
OM growth 3Y3.14%
OM growth 5Y-6.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.82%
GM growth 5Y-2.28%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF 27.56
Debt/EBITDA 7.79
Cap/Depr 46.28%
Cap/Sales 1.68%
Interest Coverage 1.23
Cash Conversion 40.59%
Profit Quality N/A
Current Ratio 3.32
Quick Ratio 1.43
Altman-Z 1.4
F-Score4
WACC7.55%
ROIC/WACC0.74
Cap/Depr(3y)41.18%
Cap/Depr(5y)40.76%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.14%
EPS 3Y-23.07%
EPS 5Y-25.75%
EPS Q2Q%-9.68%
EPS Next Y-0.7%
EPS Next 2Y15.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-5.44%
Revenue growth 5Y-1.46%
Sales Q2Q%-2.17%
Revenue Next Year-1.68%
Revenue Next 2Y-0.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.81%
EBIT growth 3Y-2.47%
EBIT growth 5Y-7.86%
EBIT Next Year33.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.46%
FCF growth 3YN/A
FCF growth 5Y-22.61%
OCF growth 1Y-22.55%
OCF growth 3Y156.62%
OCF growth 5Y-18.47%

B&G FOODS INC / BGS Fundamental Analysis FAQ

What is the fundamental rating for BGS stock?

ChartMill assigns a fundamental rating of 4 / 10 to BGS.


What is the valuation status for BGS stock?

ChartMill assigns a valuation rating of 7 / 10 to B&G FOODS INC (BGS). This can be considered as Undervalued.


What is the profitability of BGS stock?

B&G FOODS INC (BGS) has a profitability rating of 3 / 10.


How financially healthy is B&G FOODS INC?

The financial health rating of B&G FOODS INC (BGS) is 3 / 10.


What is the earnings growth outlook for B&G FOODS INC?

The Earnings per Share (EPS) of B&G FOODS INC (BGS) is expected to decline by -0.7% in the next year.